Overview and capabilities of Naobios
Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.
In the newsSee all news
Clean Mails – May 2023
New equipment for biomanufacturing
Biomanufacturing is a complex process which requires live material, experienced staff, and modern equipment. In order to generate innovative medicine from cells and viruses – inherently variable material, various tools are used to create a stable biomanufacturing environment ensuring reproducibility. An expert CDMO, Naobios increased its biomanufacturing capacity by implementing and qualifying two new Kuhner incubator shakers and one Sartorius bioreactor for process development and GMP purposes.
Save the date !
Congresses 2023: meet our teams!
Teams at Naobios are traveling the world to attend major conferences and congresses within the biotech sector. As leaders of the biopharma field, our mission and our drive at the Clean Biologics group are to remain both reachable and up-to-date with regards to the latest developments and innovations.
Clean Mails – December 2022
Naobios signs a Research License Agreement with Valneva on EB66® cell line.
Naobios today announces the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation of alternative bioprocess design and new technologies.
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.
Over 15 Years
History in GMP and Process Development Activities
of 40 people